The EMA's CHMP said the single pivotal US trial could serve as the basis for a marketing authorization application in the EU.

Ocugen (OCGN) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, reviewed the ...

Sandoz will oversee commercialization of the product across the European Union (excluding Germany), Switzerland, Norway, ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the ...

President Donald Trump said earlier this week his administration is considering reclassifying marijuana as a less dangerous drug. Here's what to know about local marijuana laws.

Given how pervasive cannabis is in New Orleans, it can sometimes be hard to believe the city was once at the forefront of ...

Polpharma Biologics S.A. (“Polpharma Biologics”) announces a global (except for Middle East & North Africa) licensing ...

On June 18, 2025, the Federal Ministry of Health (Bundesministerium für Gesundheit - BMG) published a draft bill proposing severe amendments to ...

The Nebraska Medical Cannabis Commission has set emergency rules for the medical cannabis industry, but possible participants ...

Dozens of unsecured creditors are facing losses of $3m as the fallout from the winding down of a popular medicinal cannabis company unfolds.